E-LIB Suche - Ergebnisse für: Schnadig, Ian

1

Phase Ib/II Study of Enzalutamide with Samotolisib (LY30234..:

Sweeney, Christopher J. ; Percent, Ivor J. ; Babu, Sunil...
Clinical Cancer Research. 28 (2022) 11 - p. 2237-2247 , 2022

Link: https://doi.org/10.1158/..

2

Safety and Efficacy of Nivolumab in Patients With Advanced ..:

Vogelzang, Nicholas J. ; Olsen, Mark R. ; McFarlane, Joshua J....
Clinical Genitourinary Cancer. 18 (2020) 6 - p. 461-468.e3 , 2020

Link: https://doi.org/10.1016/..

3

Safety and Efficacy of Nivolumab in Patients With Advanced ..:

McFarlane, Joshua J. ; Kochenderfer, Mark D. ; Olsen, Mark R....
Clinical Genitourinary Cancer. 18 (2020) 6 - p. 469-476.e4 , 2020

Link: https://doi.org/10.1016/..

4

APF530 versus ondansetron, each in a guideline-recommended ..:

Schnadig, Ian ; Agajanian, Richy ; Dakhil, Christopher...
Cancer Management and Research. 9 (2017) - p. 179-187 , 2017

Link: https://doi.org/10.2147/..

5

Recent developments in the clinical pharmacology of rolapit..:

Rapoport, Bernardo ; Aapro, Matti ; Chasen, Martin...
Drug Design, Development and Therapy. 11 (2017) - p. 2621-2629 , 2017

Link: https://doi.org/10.2147/..

6

Efficacy and safety of rolapitant for prevention of chemoth..:

Rapoport, Bernardo ; Schwartzberg, Lee ; Chasen, Martin...
European Journal of Cancer. 57 (2016) - p. 23-30 , 2016

Link: https://doi.org/10.1016/..

7

Efficacy of the neurokinin‐1 receptor antagonist rolapitant..:

Hesketh, Paul J. ; Schnadig, Ian D. ; Schwartzberg, Lee S....
Cancer. 122 (2016) 15 - p. 2418-2425 , 2016

Link: https://doi.org/10.1002/..

8

A Randomized, Phase II Trial of Cetuximab With or Without P..:

Bowles, Daniel W. ; Kochenderfer, Mark ; Cohn, Allen...
Clinical Colorectal Cancer. 15 (2016) 4 - p. 337-344.e2 , 2016

Link: https://doi.org/10.1016/..

9

Treatment of CD30-positive systemic mastocytosis with brent..:

Borate, Uma ; Mehta, Amitkumar ; Reddy, Vishnu...
Leukemia Research. 44 (2016) - p. 25-31 , 2016

Link: https://doi.org/10.1016/..

10

Rolapitant improves quality of life of patients receiving h..:

Chasen, Martin ; Urban, Laszlo ; Schnadig, Ian...
Supportive Care in Cancer. 25 (2016) 1 - p. 85-92 , 2016

Link: https://doi.org/10.1007/..

11

A randomized, phase 2 trial of docetaxel with or without PX..:

Jimeno, Antonio ; Bauman, Julie E. ; Weissman, Charles...
Oral Oncology. 51 (2015) 4 - p. 383-388 , 2015

Link: https://doi.org/10.1016/..

12

Clinical outcomes with bevacizumab-containing and non-bevac..:

Chen, Clara ; Ravelo, Arliene ; Yu, Elaine..
Journal of Neuro-Oncology. 122 (2015) 3 - p. 595-605 , 2015

Link: https://doi.org/10.1007/..

13

Sequencing of Cabazitaxel and Abiraterone Acetate After Doc..:

Sonpavde, Guru ; Bhor, Menaka ; Hennessy, Daniel...
Clinical Genitourinary Cancer. 13 (2015) 4 - p. 309-318 , 2015

Link: https://doi.org/10.1016/..

14

Dosing Patterns, Toxicity, and Outcomes in Patients Treated..:

Schnadig, Ian D. ; Hutson, Thomas E. ; Chung, Hsingwen...
Clinical Genitourinary Cancer. 12 (2014) 6 - p. 413-421 , 2014

Link: https://doi.org/10.1016/..

15

Light Chain Renal Amyloidosis With Prominent Giant Cells:

Troxell, Megan L. ; Griffiths, Ryan ; Schnadig, Ian.
American Journal of Kidney Diseases. 62 (2013) 6 - p. 1193-1197 , 2013

Link: https://doi.org/10.1053/..